Cargando…

PSUN251 Euglycemic DKA In A Patient Undergoing Major Surgery

BACKGROUND: Euglycemic DKA represents a diagnostic challenge as a lack of hyperglycemia can lead to a delay in recognition and administration of appropriate treatment. We present a case of euglycemic DKA in the setting of starvation and surgical stress in a patient with type 2 diabetes without SGLT2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dapas, Natalie, Baral, Neelam, Sterrett, Yamini, Sharma, Meeta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Diabetes & Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624987/ http://dx.doi.org/10.1210/jendso/bvac150.816

Ejemplares similares

PSUN240 A Case of Euglycemic DKA in Pregnancy
por: Grigoryan, Seda, et al.
Publicado: (2022)

Euglycemic DKA Associated With SGLT2 Inhibitors
por: TakallooBakhtiari, Asieh, et al.
Publicado: (2021)

ODP244 SGLT2 Inhibitor-Induced Euglycemic DKA and its Challenges
por: Penna, Laurianne El Musa, et al.
Publicado: (2022)

Euglycemic DKA in Patients on SGLT2 Inhibitor and Potentially Ketotic State
por: Khalifa, Maram, et al.
Publicado: (2021)

PSUN190 Is Euglycemic Diabetic Ketoacidosis an Underrecognized Risk of SGLT2 Inhibitor Utilization?
por: Block, Romy, et al.
Publicado: (2022)

PSUN137 Suppression of endogenous insulin secretion during euglycemic hyperinsulinemia – effects of obesity
por: Eyupoglu, Nesrin Damla, et al.
Publicado: (2022)

THU316 Relatively Rare And Increasingly Fatal; A Case Of Euglycemic DKA In A Patient With Gestational Diabetes
por: Dimech, Christina, et al.
Publicado: (2023)

Precipitation of Euglycemic DKA (euDKA) From the Initiation of SGLT2 Inhibitor (SGLT2i) and 0-Carb Diet Inpatient
por: Popli, Rakesh, et al.
Publicado: (2021)

ODP212 Inpatient Euglycemic DKA due to SGLT2 Inhibitors – Lessons From a Case Series and Strategies to Decrease Incidence
por: Burkhardt, Daniel, et al.
Publicado: (2022)

SUN-177 House Of Carbs: The Path To Euglycemic Dka In Patients With Diabetes On Sglt2 Inhibitors
por: Islam, Julie, et al.
Publicado: (2019)

A Case of Euglycemic DKA With SGLT 2 Inhibitor Use- A Diagnostic and Therapeutic Dilemma
por: Nallu, Ravali, et al.
Publicado: (2021)

LBSUN289 Ketonuria — A Possible Early Indicator Of Impending Euglycemic DKA In Setting Of Recent SGLT-2 Inhibitor Use And Acute Stress
por: Arora, Gunjan, et al.
Publicado: (2022)

PSUN267 New-Onset Type 1 Diabetes (T1D) In a Child Presenting With Diabetic Ketoacidosis (DKA) and Severe Hypertriglyceridemia Without Pancreatitis
por: Vitale, Rebecca, et al.
Publicado: (2022)

MON-LB123 Diagnosis and Management of Euglycemic DKA in the Setting of SGLT2 Inhibitor Use and Prostate Abscess
por: Rameshkumar, Naveen Sundar
Publicado: (2020)

SUN-178 A Not So "Sweet" DKA: A Case of Euglycemic Diabetic Ketoacidosis Caused by Dapagliflozin/Liraglutide Combination
por: Sideri Gugger, Aristea, et al.
Publicado: (2019)

ODP165 Atypical DKA? Think Cannabis!
por: Albashaireh, Arwa, et al.
Publicado: (2022)

SAT058 Diabetes Complicated By DKA, Mucormycosis And Covid-19
por: Gordon, Ashley
Publicado: (2023)

THU376 Isotretinoin Related DKA In Type 2 Diabetes
por: Radovanovic, Natasa, et al.
Publicado: (2023)

ODP217 Is Major Depressive Disorder in DKA Associated with Worse Patient Outcomes? A National Readmission Database Analysis
por: Ramirez, Marcelo, et al.
Publicado: (2022)

PSUN140 “Awakening of the Beta Cell(©)”
por: Jasper, Josephine, et al.
Publicado: (2022)

THU360 Hyperglycemic DKA In Patient On Monotherapy With SGLT-2 Inhibitor
por: Ahmed, Samihah, et al.
Publicado: (2023)

THU374 Fulminant Type 1 Diabetes Mellitus And DKA Secondary To Pembrolizumab
por: Iqbal, Iqra, et al.
Publicado: (2023)

PSUN274 Chlorthalidone-Induced Diabetic Ketoacidosis.
por: Zafar, Rafia, et al.
Publicado: (2022)

PSUN254 Hirata's Disease - An Unexpected Surprise
por: Al-Bahadili, Huda, et al.
Publicado: (2022)

RF28 | PSUN301 Sex Differences in the Indolepropionic Acid Alterations in Response to Obesity Surgery
por: Silva, Thaís R, et al.
Publicado: (2022)

THU247 Characterizing Inpatient Cases Of DKA Precipitated By SGLT2 Inhibitor Use
por: Aslamy, Arianne, et al.
Publicado: (2023)

FRI642 The Effect Of Early Basal Insulin Administration On Diabetic Ketoacidosis (DKA) Management
por: Al-Marsumi, Hadeel, et al.
Publicado: (2023)

RF16 | PSUN155 Empagliflozin and the risk of nephrolithiasis
por: Balasubramanian, Priyadarshini, et al.
Publicado: (2022)

PSUN169 Vitamin C Renal Leak in Diabetes
por: Ebenuwa, Ifechukwude, et al.
Publicado: (2022)

PSUN247 Unique Presentation of MODY Type 5
por: Bella, Sama, et al.
Publicado: (2022)

ODP195 EUGLYCEMIC DIABETIC KETOACIDOSIS AFTER BARIATRIC SURGERY IN ASSOCIATION WITH USE OF SGLT2I.
por: Vaghasia, Nishit, et al.
Publicado: (2022)

LBODP057 Association Between DKA And Live Abscess: Results From The National Inpatient Sample
por: Muammar, Ahmad, et al.
Publicado: (2022)

THU291 Successful Reversal Of Glucose Toxicity After DKA Precipitated By SGLT2 Inhibitor
por: Abdelrahman, Houda, et al.
Publicado: (2023)

PSUN279 Refractory Hypoglycemia in the Setting of Incidental Urothelial Carcinoma
por: Kennedy, Randol, et al.
Publicado: (2022)

PSUN176 Fructosamine as a screening test for gestational diabetes
por: Kabadi, Udaya, et al.
Publicado: (2022)

PSUN253 Cocaine Use Resulting in Inadvertent Sulfonylurea Overdose
por: Gothong, Chikara, et al.
Publicado: (2022)

PSUN277 Symptomatic Hypoglycemia Associated with Over The Counter Supplement
por: Izkhakov, Neriy, et al.
Publicado: (2022)

Selecting Patients at Risk of Developing DKA on Gliflozins
por: Maletkovic, Jelena
Publicado: (2021)

ODP192 Empagliflozin associated Euglycemic Diabetic Ketoacidosis and the Terrible Triad
por: Nievera, Karl Homer, et al.
Publicado: (2022)

THU387 Euglycemic Diabetic Ketoacidosis And SGLT-2 Inhibitor Use
por: Abrahimi, Nora, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kr067q7jvjb89t1m98sv9fi7j0